GLP Watchdog

SkinnyRx vs Wisp

SkinnyRx has an open FDA warning letter dated February 20, 2026. Wisp has none. No price lines up like for like. They share compounded oral semaglutide, but SkinnyRx's $149 is a first-month price.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

SkinnyRx / Wisp

Featured pick (affiliate partner)

SkinnyRx logo

SkinnyRx

6.3/10

Wisp logo

Wisp

7.1/10

FDA warning letters
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$248/moBrand-name semaglutide pill
$225/moCompounded oral semaglutide
States
47 states
39 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit SkinnyRx
Visit Wisp

SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Wisp pays us nothing. The scores are computed the same way for both and are shown as computed (SkinnyRx 6.3, Wisp 7.1). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. Wisp has none.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    No price lines up like for like. They share compounded oral semaglutide, but SkinnyRx's $149 is a first-month price.

  4. 04

    Only SkinnyRx lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen.

  5. 05

    SkinnyRx covers eight states Wisp does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

SkinnyRx

Wisp

Compounded oral semaglutide

$149/mo

first month only; not compared

$225/mo

$2,700 a year

Compounded semaglutide injection

$99/mo

first month only; not compared

Not sold or not priced
Compounded tirzepatide injection

$99/mo

first month only; not compared

Not sold or not priced
Brand-name semaglutide pen

$1,400/mo

$16,800 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,400/mo

$16,800 a year

Not sold or not priced
Compounded oral tirzepatide

$199/mo

first month only; not compared

Not sold or not priced
Brand-name semaglutide pill

$248/mo

$2,976 a year

Not sold or not priced
Foundayo (orforglipron) pill

$248/mo

$2,976 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Not stated
Refunds
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods
All sales are final

Read off each seller’s own pages. SkinnyRx: October 30, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for SkinnyRx

6.3/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Wisp does not price
  • Lists 47 states against 39
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

The case for Wisp

7.1/10
  • No FDA warning letter on record
  • Names no compounding pharmacy
Visit Wisp

Scores

SkinnyRx 6.3 · Wisp 7.1 out of 10. Six weighted parts.

Value25%

5.6A
vs
B
4.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

2.0A
vs
B
7.5

Accessibility10%

9.5A
vs
B
8.2

Support10%

7.0A
vs
B
4.5

The score is the same formula for every seller. Payment does not enter it. Method

SkinnyRx vs Wisp: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. Wisp has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
No price lines up like for like. They share compounded oral semaglutide, but SkinnyRx's $149 is a first-month price. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods. Wisp states you can cancel at any time; refunds: all sales are final.
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Wisp pays us nothing. The scores are computed the same way for both and are shown as computed (SkinnyRx 6.3, Wisp 7.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks